|
|
||||||||
The Journal of Immunology, Vol 148, Issue 11 3433-3440, Copyright © 1992 by American Association of Immunologists
ARTICLES |
DS Schoenhaut, AO Chua, AG Wolitzky, PM Quinn, CM Dwyer, W McComas, PC Familletti, MK Gately and U Gubler
Department of Molecular Genetics, Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110-1197.
Human IL-12 (NK cell stimulatory factor, cytotoxic lymphocyte maturation factor) is a heterodimeric cytokine that can act as a growth factor for activated human T and NK cells, enhance the lytic activity of human NK/lymphokine-activated killer cells, and stimulate the production of IFN-gamma by resting human PBMC. Because in our hands, human IL-12 did not elicit similar responses in murine lymphocytes, we have cloned and expressed the murine IL-12 subunit cDNA in order to obtain recombinant protein for murine studies. Comparison of the predicted amino acid sequences of the murine subunits with their human counterparts revealed that the p40 subunits are more highly conserved than the p35 subunits (70% vs 60% identity, respectively). The sizes of the p35 and p40 subunit mRNA were estimated to be 1.5 kb and 2.6 kb, respectively. RNA blot analysis showed that p35 mRNA was expressed in lymphoid tissues (spleen, thymus) and nonlymphoid tissues (lung, brain), whereas p40 mRNA expression was only detected in lymphoid cells. Incubation of splenocytes with pokeweed mitogen did not significantly affect p35 mRNA levels, however, it resulted in a decrease of p40 mRNA. Coexpression of the murine p35 and p40 cDNA clones in COS cells resulted in the secretion of IL-12, which was active in human and mouse T cell proliferation, murine NK cell activation, and murine IFN-gamma induction assays. Transfection of each subunit cDNA alone did not result in measurable secreted IL-12 activity. A hybrid heterodimer consisting of murine p35 and human p40 subunits retained bioactivity on murine cells; however, the combination of human p35 and murine p40 was completely inactive on murine cells. These results indicate that the observed inability of human IL-12 to act on murine cells is largely determined by the p35 subunit.
This article has been cited by other articles:
![]() |
D.-J. Kim, J.-I. Youn, S.-H. Seo, H.-T. Jin, and Y.-C. Sung Differential Regulation of Antigen-Specific CD8+ T Cell Responses by IL-12p40 in a Dose-Dependent Manner J. Immunol., June 1, 2008; 180(11): 7167 - 7174. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jayakumar, M. J. Donovan, V. Tripathi, M. Ramalho-Ortigao, and M. A. McDowell Leishmania major Infection Activates NF-{kappa}B and Interferon Regulatory Factors 1 and 8 in Human Dendritic Cells Infect. Immun., May 1, 2008; 76(5): 2138 - 2148. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakano, C. Nishiyama, S. Kanada, Y. Niwa, N. Shimokawa, H. Ushio, M. Nishiyama, K. Okumura, and H. Ogawa Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections Blood, June 1, 2007; 109(11): 4846 - 4855. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Carmona, R. Vassallo, Z. Vuk-Pavlovic, J. E. Standing, T. J. Kottom, and A. H. Limper Pneumocystis Cell Wall beta-Glucans Induce Dendritic Cell Costimulatory Molecule Expression and Inflammatory Activation through a Fas-Fas Ligand Mechanism J. Immunol., July 1, 2006; 177(1): 459 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Helguera, J. A. Rodriguez, and M. L. Penichet Cytokines fused to antibodies and their combinations as therapeutic agents against different peritoneal HER2/neu expressing tumors. Mol. Cancer Ther., April 1, 2006; 5(4): 1029 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Heinonen, N. Dube, A. Bourdeau, W. S. Lapp, and M. L. Tremblay Protein tyrosine phosphatase 1B negatively regulates macrophage development through CSF-1 signaling PNAS, February 21, 2006; 103(8): 2776 - 2781. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhou, E. A. Lafleur, N. V. Koshkina, L. L. Worth, M. S. Lester, and E. S. Kleinerman Interleukin-12 Up-Regulates Fas Expression in Human Osteosarcoma and Ewing's Sarcoma Cells by Enhancing Its Promoter Activity Mol. Cancer Res., December 1, 2005; 3(12): 685 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Dickerson, N. Akhtar, H. Steinberg, Z.-Y. Wang, M. J. Lindstrom, M. L. Padilla, R. Auerbach, and S. C. Helfand Enhancement of the Antiangiogenic Activity of Interleukin-12 by Peptide Targeted Delivery of the Cytokine to {alpha}v{beta}3 Integrin Mol. Cancer Res., December 1, 2004; 2(12): 663 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Wong, M.-K. Chan, Z. Yu, R. A. Ghossein, I. Ngai, P. S. Adusumilli, B. M. Stiles, J. P. Shah, B. Singh, and Y. Fong Angiogenesis Inhibition by an Oncolytic Herpes Virus Expressing Interleukin 12 Clin. Cancer Res., July 1, 2004; 10(13): 4509 - 4516. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Heinonen, F. P. Nestel, E. W. Newell, G. Charette, T. A. Seemayer, M. L. Tremblay, and W. S. Lapp T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease Blood, May 1, 2004; 103(9): 3457 - 3464. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Luo, X. Ma, S. M. Wahl, J. J. Bieker, M. Crossley, and L. J. Montaner Activation and Repression of Interleukin-12 p40 Transcription by Erythroid Kruppel-like Factor in Macrophages J. Biol. Chem., April 30, 2004; 279(18): 18451 - 18456. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zabala, L. Wang, R. Hernandez-Alcoceba, W. Hillen, C. Qian, J. Prieto, and M. G. Kramer Optimization of the Tet-on System To Regulate Interleukin 12 Expression in the Liver for the Treatment of Hepatic Tumors Cancer Res., April 15, 2004; 64(8): 2799 - 2804. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xiong, C. Zhu, F. Li, R. Hegazi, K. He, M. Babyatsky, A. J. Bauer, and S. E. Plevy Inhibition of Interleukin-12 p40 Transcription and NF-{kappa}B Activation by Nitric Oxide in Murine Macrophages and Dendritic Cells J. Biol. Chem., March 12, 2004; 279(11): 10776 - 10783. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Simpson, M. S. Mistry, R. A. Maki, W. Yang, D. A. Schwarz, E. B. Johnson, F. M. Lio, and D. G. Alleva Cutting Edge: Diabetes-Associated Quantitative Trait Locus, Idd4, Is Responsible for the IL-12p40 Overexpression Defect in Nonobese Diabetic (NOD) Mice J. Immunol., October 1, 2003; 171(7): 3333 - 3337. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Jordan, M. T. Preissler, J. A. Banas, and E. J. Gosselin Production of Genetically Engineered Biotinylated Interleukin-2 and Its Application in a Rapid Nonradioactive Assay for T-Cell Activation Clin. Vaccine Immunol., May 1, 2003; 10(3): 339 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zhang and L. J. DeGroot Gene Therapy of a Rat Follicular Thyroid Carcinoma Model with Adenoviral Vectors Transducing Murine Interleukin-12 Endocrinology, April 1, 2003; 144(4): 1393 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Camon, M. Magrane, D. Barrell, D. Binns, W. Fleischmann, P. Kersey, N. Mulder, T. Oinn, J. Maslen, A. Cox, et al. The Gene Ontology Annotation (GOA) Project: Implementation of GO in SWISS-PROT, TrEMBL, and InterPro Genome Res., April 1, 2003; 13(4): 662 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kikawada, D. M. Lenda, and V. R. Kelley IL-12 Deficiency in MRL-Faslpr Mice Delays Nephritis and Intrarenal IFN-{gamma} Expression, and Diminishes Systemic Pathology J. Immunol., April 1, 2003; 170(7): 3915 - 3925. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Leong, J. C. C. Chang, R. Ong, G. Dawes, W. P. C. Stemmer, and J. Punnonen Optimized expression and specific activity of IL-12 by directed molecular evolution PNAS, February 4, 2003; 100(3): 1163 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. R. Lankford and D. M. Frucht A unique role for IL-23 in promoting cellular immunity J. Leukoc. Biol., January 1, 2003; 73(1): 49 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Hess, N. K. Egilmez, N. Bailey, T. M. Anderson, E. Mathiowitz, S. H. Bernstein, and R. B. Bankert Human CD4+ T Cells Present Within the Microenvironment of Human Lung Tumors Are Mobilized by the Local and Sustained Release of IL-12 to Kill Tumors In Situ by Indirect Effects of IFN-{gamma} J. Immunol., January 1, 2003; 170(1): 400 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Eyles, D. Metcalf, M. J. Grusby, D. J. Hilton, and R. Starr Negative Regulation of Interleukin-12 Signaling by Suppressor of Cytokine Signaling-1 J. Biol. Chem., November 8, 2002; 277(46): 43735 - 43740. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bilsborough, C. Uyttenhove, D. Colau, P. Bousso, C. Libert, B. Weynand, T. Boon, and B. J. Van den Eynde TNF-Mediated Toxicity After Massive Induction of Specific CD8+ T Cells Following Immunization of Mice with a Tumor-Specific Peptide J. Immunol., September 15, 2002; 169(6): 3053 - 3060. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Peter, M. J. Brunda, and G. Corradin IL-12 Administration Leads to a Transient Depletion of T Cells, B Cells, and APCs and Concomitant Abrogation of the HLA-A2.1-Restricted CTL Response in Transgenic Mice J. Immunol., July 1, 2002; 169(1): 63 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Prakash, Z.-Y. Tang, X. Peng, R. Coleman, J. Gill, G. Farr, and F. Samaniego Tumorigenesis and Aberrant Signaling in Transgenic Mice Expressing the Human Herpesvirus-8 K1 Gene J Natl Cancer Inst, June 19, 2002; 94(12): 926 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagarajan and P. Selvaraj Glycolipid-anchored IL-12 Expressed on Tumor Cell Surface Induces Antitumor Immune Response Cancer Res., May 1, 2002; 62(10): 2869 - 2874. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Palendira, A. T. Kamath, C. G. Feng, E. Martin, P. J. Chaplin, J. A. Triccas, and W. J. Britton Coexpression of Interleukin-12 Chains by a Self-Splicing Vector Increases the Protective Cellular Immune Response of DNA and Mycobacterium bovis BCG Vaccines against Mycobacterium tuberculosis Infect. Immun., April 1, 2002; 70(4): 1949 - 1956. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Frucht IL-23: A Cytokine That Acts on Memory T Cells Sci. Signal., January 8, 2002; 2002(114): pe1 - pe1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kollet, C. Witek, J. D. Gentry, X. Liu, S. D. Schwartzbach, and T. M. Petro Deletional Analysis of the Murine IL-12 p35 Promoter Comparing IFN-{gamma} and Lipopolysaccharide Stimulation J. Immunol., November 15, 2001; 167(10): 5653 - 5663. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sun, A. R. Muthukumar, R. A. Lawrence, and G. Fernandes Effects of Calorie Restriction on Polymicrobial Peritonitis Induced by Cecum Ligation and Puncture in Young C57BL/6 Mice Clin. Vaccine Immunol., September 1, 2001; 8(5): 1003 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shiratori, M. Matsumoto, S. Tsuji, M. Nomura, K. Toyoshima, and T. Seya Molecular cloning and functional characterization of guinea pig IL-12 Int. Immunol., September 1, 2001; 13(9): 1129 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Becker, S. Wirtz, X. Ma, M. Blessing, P. R. Galle, and M. F. Neurath Regulation of IL-12 p40 Promoter Activity in Primary Human Monocytes: Roles of NF-{kappa}B, CCAAT/Enhancer-Binding Protein {beta}, and PU.1 and Identification of a Novel Repressor Element (GA-12) That Responds to IL-4 and Prostaglandin E2 J. Immunol., September 1, 2001; 167(5): 2608 - 2618. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. L. Stuyt, M. G. Netea, S.-H. Kim, D. Novick, M. Rubinstein, B.-J. Kullberg, J. W. M. Van der Meer, and C. A. Dinarello Differential Roles of Interleukin-18 (IL-18) and IL-12 for Induction of Gamma Interferon by Staphylococcal Cell Wall Components and Superantigens Infect. Immun., August 1, 2001; 69(8): 5025 - 5030. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Wiekowski, M. W. Leach, E. W. Evans, L. Sullivan, S.-C. Chen, G. Vassileva, J. F. Bazan, D. M. Gorman, R. A. Kastelein, S. Narula, et al. Ubiquitous Transgenic Expression of the IL-23 Subunit p19 Induces Multiorgan Inflammation, Runting, Infertility, and Premature Death J. Immunol., June 15, 2001; 166(12): 7563 - 7570. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Lafleur, S.-F. Jia, L. L. Worth, Z. Zhou, L. B. Owen-Schaub, and E. S. Kleinerman Interleukin (IL)-12 and IL-12 Gene Transfer Up-Regulate Fas Expression in Human Osteosarcoma and Breast Cancer Cells Cancer Res., May 1, 2001; 61(10): 4066 - 4071. [Abstract] [Full Text] |
||||
![]() |
J. R. TIMOSHANKO, A. R. KITCHING, S. R. HOLDSWORTH, and P. G. TIPPING Interleukin-12 from Intrinsic Cells Is an Effector of Renal Injury in Crescentic Glomerulonephritis J. Am. Soc. Nephrol., March 1, 2001; 12(3): 464 - 471. [Abstract] [Full Text] |
||||
![]() |
M. J. Walter, N. Kajiwara, P. Karanja, M. Castro, and M. J. Holtzman Interleukin 12 p40 Production by Barrier Epithelial Cells during Airway Inflammation J. Exp. Med., January 29, 2001; 193(3): 339 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fujita, J. M. Shannon, C. G. Irvin, K. A. Fagan, C. Cool, A. Augustin, and R. J. Mason Overexpression of tumor necrosis factor-{alpha} produces an increase in lung volumes and pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, January 1, 2001; 280(1): L39 - L49. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-y. Wu, X. Wang, M. Gadina, J. J. O'Shea, D. H. Presky, and J. Magram IL-12 Receptor {beta}2 (IL-12R{beta}2)-Deficient Mice Are Defective in IL-12-Mediated Signaling Despite the Presence of High Affinity IL-12 Binding Sites J. Immunol., December 1, 2000; 165(11): 6221 - 6228. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Worth, S.-F. Jia, Z. Zhou, L. Chen, and E. S. Kleinerman Intranasal Therapy with an Adenoviral Vector Containing the Murine Interleukin-12 Gene Eradicates Osteosarcoma Lung Metastases Clin. Cancer Res., September 1, 2000; 6(9): 3713 - 3718. [Abstract] [Full Text] |
||||
![]() |
B. R. Lauwerys, N. Garot, J.-C. Renauld, and F. A. Houssiau Cytokine Production and Killer Activity of NK/T-NK Cells Derived with IL-2, IL-15, or the Combination of IL-12 and IL-18 J. Immunol., August 15, 2000; 165(4): 1847 - 1853. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Geng, K. Berencsi, Z. Gyulai, T. Valyi-Nagy, E. Gonczol, and G. Trinchieri Roles of Interleukin-12 and Gamma Interferon in Murine Chlamydia pneumoniae Infection Infect. Immun., April 1, 2000; 68(4): 2245 - 2253. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pedrosa, B. M. Saunders, R. Appelberg, I. M. Orme, M. T. Silva, and A. M. Cooper Neutrophils Play a Protective Nonphagocytic Role in Systemic Mycobacterium tuberculosis Infection of Mice Infect. Immun., February 1, 2000; 68(2): 577 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Pien and C. A. Biron Compartmental Differences in NK Cell Responsiveness to IL-12 During Lymphocytic Choriomeningitis Virus Infection J. Immunol., January 15, 2000; 164(2): 994 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado and D. Ganea Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Interleukin-12 Transcription by Regulating Nuclear Factor kappa B and Ets Activation J. Biol. Chem., November 5, 1999; 274(45): 31930 - 31940. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jiang, D. M. Magee, and R. A. Cox Coadministration of Interleukin 12 Expression Vector with Antigen 2 cDNA Enhances Induction of Protective Immunity against Coccidioides immitis Infect. Immun., November 1, 1999; 67(11): 5848 - 5853. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. MEMOLI, L. MARZANO, V. BISESTI, M. ANDREUCCI, and B. GUIDA Hemodialysis-Related Lymphomononuclear Release of Interleukin-12 in Patients with End-Stage Renal Disease J. Am. Soc. Nephrol., October 1, 1999; 10(10): 2171 - 2176. [Abstract] [Full Text] |
||||
![]() |
K F Chung and P J Barnes Cytokines in asthma Thorax, September 1, 1999; 54(9): 825 - 857. [Full Text] |
||||
![]() |
C. A. Salkowski, K. Kopydlowski, J. Blanco, M. J. Cody, R. McNally, and S. N. Vogel IL-12 Is Dysregulated in Macrophages from IRF-1 and IRF-2 Knockout Mice J. Immunol., August 1, 1999; 163(3): 1529 - 1536. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Peng, M. L. Penichet, and S. L. Morrison A Single-Chain IL-12 IgG3 Antibody Fusion Protein Retains Antibody Specificity and IL-12 Bioactivity and Demonstrates Antitumor Activity J. Immunol., July 1, 1999; 163(1): 250 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jiang, D. M. Magee, and R. A. Cox Construction of a Single-Chain Interleukin-12-Expressing Retroviral Vector and Its Application in Cytokine Gene Therapy against Experimental Coccidioidomycosis Infect. Immun., June 1, 1999; 67(6): 2996 - 3001. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamane, T. Kato, and H. Nariuchi Effective Stimulation for IL-12 p35 mRNA Accumulation and Bioactive IL-12 Production of Antigen-Presenting Cells Interacted with Th Cells J. Immunol., June 1, 1999; 162(11): 6433 - 6441. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Babik, E. Adams, Y. Tone, P. J. Fairchild, M. Tone, and H. Waldmann Expression of Murine IL-12 Is Regulated by Translational Control of the p35 Subunit J. Immunol., April 1, 1999; 162(7): 4069 - 4078. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sam and M. M. Stevenson In Vivo IL-12 Production and IL-12 Receptors {beta}1 and {beta}2 mRNA Expression in the Spleen Are Differentially Up-Regulated in Resistant B6 and Susceptible A/J Mice During Early Blood-Stage Plasmodium chabaudi AS Malaria J. Immunol., February 1, 1999; 162(3): 1582 - 1589. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Tarrant, P. B. Silver, J. L. Wahlsten, L. V. Rizzo, C.-C. Chan, B. Wiggert, and R. R. Caspi Interleukin 12 Protects from a T Helper Type 1-mediated Autoimmune Disease, Experimental Autoimmune Uveitis, through a Mechanism Involving Interferon gamma , Nitric Oxide, and Apoptosis J. Exp. Med., January 18, 1999; 189(2): 219 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hasan, S. Najjam, M. Y. Gordon, R. V. Gibbs, and C. C. Rider IL-12 Is a Heparin-Binding Cytokine J. Immunol., January 15, 1999; 162(2): 1064 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Penny, R. A. Boyd, and B. M. Hall Permanent CD8+ T Cell Depletion Prevents Proteinuria in Active Heymann Nephritis J. Exp. Med., November 16, 1998; 188(10): 1775 - 1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Tarrant, P. B. Silver, C.-C. Chan, B. Wiggert, and R. R. Caspi Endogenous IL-12 Is Required for Induction and Expression of Experimental Autoimmune Uveitis J. Immunol., July 1, 1998; 161(1): 122 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Monteiro, C. Harvey, and G. Trinchieri Role of Interleukin-12 in Primary Influenza Virus Infection J. Virol., June 1, 1998; 72(6): 4825 - 4831. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Homey, T. Assmann, H.-W. Vohr, P. Ulrich, A. I. Lauerma, T. Ruzicka, P. Lehmann, and H.-C. Schuppe Topical FK506 Suppresses Cytokine and Costimulatory Molecule Expression in Epidermal and Local Draining Lymph Node Cells During Primary Skin Immune Responses J. Immunol., June 1, 1998; 160(11): 5331 - 5340. [Abstract] |